Metraipolis › archive › dc_e3be89af12e5

Integrative multi-omics identifies DOC2A as a novel pharmacological target for bipolar disorder — Europe PMC PMID:42206661

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42206661
DOI
10.1017/s0033291726104565
License (as archived)
solo-consultazione
Archived
2026-10-09T22:42:05.362Z
SHA-256 of the archived text
d7f5dbfecef666e9a103aded5a76704ba4cd9799d54d3cd8ad58fd39e9675ec6
Stable URL of this page
https://metraipolis.com/documento/dc_e3be89af12e5

How to cite

Integrative multi-omics identifies DOC2A as a novel pharmacological target for bipolar disorder — Europe PMC PMID:42206661 — Europe PMC (en), https://europepmc.org/article/MED/42206661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e3be89af12e5 (Metraipolis archive dc_e3be89af12e5, sha256 d7f5dbfecef666e9a103aded5a76704ba4cd9799d54d3cd8ad58fd39e9675ec6)
BibTeX
@misc{dce3be89af12e5,
  title = {Integrative multi-omics identifies DOC2A as a novel pharmacological target for bipolar disorder — Europe PMC PMID:42206661},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42206661},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e3be89af12e5; sha256 d7f5dbfecef666e9a103aded5a76704ba4cd9799d54d3cd8ad58fd39e9675ec6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42206661. Agents can read the archived copy with the MCP tool read_document.